Preclinical studies of an insulin candidate named NNC2215 have shown promise; this smart insulin can alter its own activity in response to glucose concentration in the body
Preclinical studies of an insulin candidate named NNC2215 have shown promise; this smart insulin can alter its own activity in response to glucose concentration in the body